menu
    • menu

    Company profile for Acer Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acer’s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; ACER-001 (a fully taste-mask...
    Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acer’s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; ACER-001 (a fully taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acer TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Gateway Center, Suite 351 (300 Washington Street), Newton, MA 02458
    Telephone
    Telephone
    (844) 902-6100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.acertx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/acertherapeutic?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zevra Therapeutics Completes Acquisition of Acer Therapeutics
    Zevra Therapeutics Completes Acquisition of Acer Therapeutics

    20 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/11/20/2783148/16626/en/Zevra-Therapeutics-Completes-Acquisition-of-Acer-Therapeutics-in-its-Journey-to-Become-a-Leading-Rare-Disease-Company.html

    GLOBENEWSWIRE
    20 Nov 2023
    Share Share
    ISS Recommend Acer Therapeutics Shareholders Vote \FOR\
    ISS Recommend Acer Therapeutics Shareholders Vote FOR" the Proposed Merger"

    02 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/02/2772310/0/en/Leading-Independent-Proxy-Advisory-Firms-ISS-and-Glass-Lewis-Recommend-Acer-Therapeutics-Shareholders-Vote-FOR-the-Proposed-Merger-and-Related-Proposals.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share
    Relief Announces New Exclusive Definitive Agreement for OLPRUVA(TM) (ACER-001)
    Relief Announces New Exclusive Definitive Agreement for OLPRUVA(TM) (ACER-001)

    30 Aug 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=778812&lang=en

    ACCESSWIRE
    30 Aug 2023
    Share Share
    Acer Reacquires Worldwide Development, Commercialization Rights to OLPRUVA
    Acer Reacquires Worldwide Development, Commercialization Rights to OLPRUVA

    30 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/30/2734780/0/en/Acer-Therapeutics-Reacquires-Worldwide-Development-Commercialization-and-Economic-Rights-to-OLPRUVA-from-Relief-Therapeutics-Excluding-the-Geographical-Europe.html

    GLOBENEWSWIRE
    30 Aug 2023
    Share Share
    Acer Therapeutics Reports Second Quarter 2023 Financial Results
    Acer Therapeutics Reports Second Quarter 2023 Financial Results

    14 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/14/2725006/0/en/Acer-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    14 Aug 2023
    Share Share
    Acer Receives $1M Capital Infusion from Chief Executive Officer and Founder
    Acer Receives $1M Capital Infusion from Chief Executive Officer and Founder

    26 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/26/2694449/0/en/Acer-Therapeutics-Receives-1-Million-Capital-Infusion-from-Chief-Executive-Officer-and-Founder.html

    GLOBENEWSWIRE
    26 Jun 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search